CEROW
CERo Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−26.92%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-68.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 9, 2026 | Rolfe Lindsey · director | A-Award | 690,900 | $0.06 |
| Jan 9, 2026 | LAPORTE KATHLEEN · director | A-Award | 690,900 | $0.06 |
| Jan 9, 2026 | Pierce Kristen · officer: Chief Development Officer | A-Award | 1,612,099 | $0.06 |
| Jan 9, 2026 | Patel Shami · director | A-Award | 690,900 | $0.06 |
| Jan 9, 2026 | ATWOOD BRIAN G · director | A-Award | 1,612,099 | $0.06 |
| Jan 9, 2026 | Ehrlich Christopher B · director, officer: Chairman and CEO | A-Award | 4,530,997 | $0.06 |
| Jan 9, 2026 | Byrnes Michael · director | A-Award | 690,900 | $0.06 |
| Jan 9, 2026 | KUCHARCHUK ANDREW ALBERT · officer: Chief Financial Officer | A-Award | 1,162,099 | $0.06 |
| Jun 2, 2025 | LAPORTE KATHLEEN · director | A-Award | 9,326 | $0.45 |
| Jun 2, 2025 | Byrnes Michael · director | A-Award | 9,326 | $0.45 |
| Jun 2, 2025 | Rolfe Lindsey · director | A-Award | 9,326 | $0.45 |
| Jun 2, 2025 | Patel Shami · director | A-Award | 11,693 | $0.45 |
| Jun 2, 2025 | Ehrlich Christopher B · director, officer: Chairman and CEO | A-Award | 61,843 | $0.45 |
| Jun 2, 2025 | ATWOOD BRIAN G · director | A-Award | 122,549 | $0.45 |
| Jun 2, 2025 | Pierce Kristen · officer: Chief Development Officer | A-Award | 154,841 | $0.45 |
| Jun 2, 2025 | KUCHARCHUK ANDREW ALBERT · officer: Chief Financial Officer | A-Award | 152,500 | $0.45 |
| Apr 4, 2025 | ATWOOD BRIAN G · director | M-Exempt | 294,460 | $0.00 |
| Mar 6, 2025 | Ehrlich Christopher B · director, officer: Chairman and CEO | A-Award | 119,486 | $1.43 |
| Feb 26, 2025 | Rolfe Lindsey · director | A-Award | 127,500 | $0.10 |
| Feb 26, 2025 | Patel Shami · director | A-Award | 127,500 | $0.10 |
| Feb 26, 2025 | LAPORTE KATHLEEN · director | A-Award | 127,500 | $0.10 |
| Feb 26, 2025 | Ehrlich Christopher B · director, officer: Chairman and CEO | A-Award | 1,275,000 | $0.10 |
| Feb 26, 2025 | Byrnes Michael · director | A-Award | 127,500 | $0.10 |
| Feb 26, 2025 | ATWOOD BRIAN G · director | A-Award | 254,000 | $0.10 |
| Feb 7, 2025 | ATWOOD BRIAN G · director | A-Award | 306,120 | $1.96 |
| Feb 7, 2025 | ATWOOD BRIAN G · director | A-Award | 204,080 | $1.96 |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC · 10 percent owner | Sale | 1,343,801 | $0.08 |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC · 10 percent owner | Sale | 1,614,541 | $0.07 |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC · 10 percent owner | Sale | 2,998,908 | $0.06 |
| Dec 10, 2024 | YK Bioventures Opportunities GP I, LLC · 10 percent owner | Sale | 1,236,874 | $0.12 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Ancora Advisors LLC | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 9, 2026